tiprankstipranks
Trending News
More News >
Trellus Health PLC (GB:TRLS)
LSE:TRLS
Advertisement

Trellus Health PLC (TRLS) Price & Analysis

Compare
2 Followers

TRLS Stock Chart & Stats


Trellus Health PLC News

TRLS FAQ

What was Trellus Health PLC’s price range in the past 12 months?
Trellus Health PLC lowest share price was 0.50p and its highest was 5.40p in the past 12 months.
    What is Trellus Health PLC’s market cap?
    Trellus Health PLC’s market cap is £1.13M.
      When is Trellus Health PLC’s upcoming earnings report date?
      Trellus Health PLC’s upcoming earnings report date is Sep 25, 2025 which is in 26 days.
        How were Trellus Health PLC’s earnings last quarter?
        Trellus Health PLC released its earnings results on Jun 02, 2025. The company reported -0.019p earnings per share for the quarter, missing the consensus estimate of N/A by -0.019p.
          Is Trellus Health PLC overvalued?
          According to Wall Street analysts Trellus Health PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Trellus Health PLC pay dividends?
            Trellus Health PLC does not currently pay dividends.
            What is Trellus Health PLC’s EPS estimate?
            Trellus Health PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Trellus Health PLC have?
            Trellus Health PLC has 161,508,330 shares outstanding.
              What happened to Trellus Health PLC’s price movement after its last earnings report?
              Trellus Health PLC reported an EPS of -0.019p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -38.889%.
                Which hedge fund is a major shareholder of Trellus Health PLC?
                Currently, no hedge funds are holding shares in GB:TRLS

                Company Description

                Trellus Health PLC

                Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.

                Trellus Health PLC (TRLS) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                MyHealthChecked PLC
                IXICO plc
                Oxford BioDynamics
                Verici Dx Plc

                Ownership Overview

                <0.01%100.00%
                Insiders
                <0.01%
                Mutual Funds
                ― Other Institutional Investors
                100.00% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis